Journey Medical (DERM) Common Equity (2020 - 2026)
Journey Medical's (DERM) quarterly Common Equity came in at $30.8 million in Q1 2026, up 43.13% YoY from $21.5 million in Q1 2025, and down 3.21% on a QoQ basis from $31.9 million in Q4 2025.
Journey Medical (DERM) Common Equity (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Common Equity data on file, last reported at $30.8 million in Q1 2026.
- Quarterly Common Equity rose 43.13% year-over-year to $30.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.8 million (up 43.13% YoY) and the FY2025 annual result came in at $31.9 million, up 58.71% from the prior year.
- Common Equity declined to $30.8 million in Q1 2026, from $31.9 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $41.4 million in Q1 2022 to a low of $5000.0 in Q2 2023.
- A 5-year average of $20.5 million and a median of $20.1 million in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2023 — Common Equity slumped 99.99% — and 2024, when it soared 225800.0%.
- Tracing DERM's Common Equity over 5 years: stood at $17.0 million in 2022, then rose by 19.83% to $20.3 million in 2023, then fell by 1.38% to $20.1 million in 2024, then soared by 58.71% to $31.9 million in 2025, then fell by 3.21% to $30.8 million in 2026.
- The last three Common Equity figures came in at $30.8 million (Q1 2026), $31.9 million (Q4 2025), and $25.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 4.05 Bn |
| 10 | Journey Medical | 205.38 Mn | 179.73 Mn | 12.37 Mn | 32.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.11 Mn |
| Mar 31, 2026 | 30.83 Mn |
| Dec 31, 2025 | 31.85 Mn |
| Sep 30, 2025 | 25.90 Mn |
| Jun 30, 2025 | 19.25 Mn |
| Mar 31, 2025 | 21.54 Mn |
| Dec 31, 2024 | 20.07 Mn |
| Sep 30, 2024 | 10.93 Mn |
| Jun 30, 2024 | 11.30 Mn |
| Mar 31, 2024 | 12.95 Mn |
| Dec 31, 2023 | 20.35 Mn |
| Sep 30, 2023 | 17.37 Mn |
| Jun 30, 2023 | 5,000.00 |
| Mar 31, 2023 | 7.49 Mn |
| Dec 31, 2022 | 16.98 Mn |
| Sep 30, 2022 | 26.18 Mn |
| Jun 30, 2022 | 34.80 Mn |
| Mar 31, 2022 | 41.44 Mn |
| Dec 31, 2021 | 42.04 Mn |
| Sep 30, 2021 | -11.71 Mn |